<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13-pharmaceuticals-13-00455">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kanai</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Imaizumi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Otsuka</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sasaki</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hashiguchi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Tsujiko</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Matsumoto</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ishiguro</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Chiba</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers</article-title>
  <source>Cancer Chemother. Pharmacol.</source>
  <year>2012</year>
  <volume>69</volume>
  <fpage>65</fpage>
  <lpage>70</lpage>
  <pub-id pub-id-type="doi">10.1007/s00280-011-1673-1</pub-id>
  <?supplied-pmid 21603867?>
  <pub-id pub-id-type="pmid">21603867</pub-id>
 </element-citation>
</ref>
